SwePub
Sök i LIBRIS databas

  Extended search

WFRF:(Ljunggren Mirjam)
 

Search: WFRF:(Ljunggren Mirjam) > Nasal polyposis is ...

  • Bengtsson, CarolineUppsala University,Uppsala universitet,Öron-, näs- och halssjukdomar (author)

Nasal polyposis is a risk factor for nonadherence to CPAP treatment in sleep apnea: the population-based DISCOVERY study

  • Article/chapterEnglish2023

Publisher, publication year, extent ...

  • American Academy of Sleep Medicine (AASM),2023

Numbers

  • LIBRIS-ID:oai:gup.ub.gu.se/330851
  • https://gup.ub.gu.se/publication/330851URI
  • https://doi.org/10.5664/jcsm.10390DOI
  • https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-510642URI
  • https://lup.lub.lu.se/record/4f9f9b34-6b7a-47d0-bd35-f88f3705dabdURI

Supplementary language notes

  • Language:English

Part of subdatabase

Classification

  • Subject category:ref swepub-contenttype
  • Subject category:art swepub-publicationtype

Notes

  • Study Objectives: The aim was to evaluate nasal polyposis as a risk factor for nonadherence to continuous positive airway pressure (CPAP) treatment in patients with obstructive sleep apnea (OSA). Methods: This was a population-based, longitudinal analysis of patients starting CPAP treatment for OSA in the Swedish quality registry Swedevox between 2010 and 2018. Data were cross-linked with national registries. The impact of nasal polyposis on CPAP adherence was analyzed using uni-and multivariable logistic and linear regression models. Relevant confounders (age, sex, usage of nasal and oral steroids) were identified using a direct acyclic graph. Results: Of 20,521 patients with OSA on CPAP treatment (29.5% females), 331 (1.6%) had a diagnosis of nasal polyposis at baseline. At the 1-year follow-up, nasal polyposis was associated with an increased risk of CPAP usage < 4 hours/night (unadjusted odds ratio [OR] 1.21; 95% confidence interval [CI] 0.95-1.55); adjusted OR 1.38; 95% CI 1.08-1.77). In this group, unadjusted nocturnal mean CPAP usage was 15.4 minutes (95% CI-31.62 to 0.83) shorter and was an adjusted 24.1 minutes (95% CI-40.6 to-7.7) shorter compared with patients with OSA without nasal polyposis. Conclusions: Nasal polyposis is associated with reduced CPAP usage per night. These results highlight the importance of diagnosing nasal polyposis in patients with OSA before the start of CPAP treatment. Treatment of the condition may improve adherence, efficacy, and patient outcomes.

Subject headings and genre

Added entries (persons, corporate bodies, meetings, titles ...)

  • Grote, Ludger,1964Gothenburg University,Göteborgs universitet,Institutionen för medicin,Institute of Medicine,Sahlgrens Univ Hosp, Sleep Disorders Ctr, Pulm Dept, Gothenburg, Sweden.;Gothenburg Univ, Sahlgrenska Acad, Ctr Sleep & Wake Disorders, Gothenburg, Sweden.,Sahlgrenska Academy,Sahlgrenska University Hospital(Swepub:gu)xgrolu (author)
  • Ljunggren, MirjamUppsala University,Uppsala universitet,Lung- allergi- och sömnforskning(Swepub:uu)mirlj221 (author)
  • Ekström, MagnusLund University,Lunds universitet,Andfåddhet och kronisk andningssvikt,Forskargrupper vid Lunds universitet,Breathlessness and chronic respiratory failure,Lund University Research Groups(Swepub:lu)med-mue (author)
  • Palm, Andreas,1971-Uppsala University,Uppsala universitet,Lung- allergi- och sömnforskning,Centrum för klinisk forskning, Gävleborg(Swepub:uu)andpa501 (author)
  • Uppsala universitetÖron-, näs- och halssjukdomar (creator_code:org_t)

Related titles

  • In:JOURNAL OF CLINICAL SLEEP MEDICINE: American Academy of Sleep Medicine (AASM)19:3, s. 573-5791550-93891550-9397

Internet link

Find in a library

To the university's database

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view